pLenti_dCas9-KRAB-MeCP2_Blast
(Plasmid
#221501)
-
PurposeLentiviral construct for expression of the dCas9-KRAB-MeCP2 CRISPRi vector
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 221501 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonelentiCas9-Blast
-
Backbone manufacturerAddgene #52962
- Backbone size w/o insert (bp) 12859
-
Vector typeMammalian Expression, Lentiviral, CRISPR
-
Selectable markersBlasticidin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namedCas9-KRAB-MeCP2-T2A-Blast
-
SpeciesSynthetic
-
Insert Size (bp)5778
-
MutationCas9 mutations to make dCas9=D10A+D839A+H840A+N863A
- Promoter CMV
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (not destroyed)
- 3′ cloning site NheI (not destroyed)
- 5′ sequencing primer CMV-w
- 3′ sequencing primer WPRE-Rv (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pLenti_dCas9-KRAB-MeCP2_Blast was a gift from Matthew Meyerson (Addgene plasmid # 221501 ; http://n2t.net/addgene:221501 ; RRID:Addgene_221501) -
For your References section:
Dosage amplification dictates oncogenic regulation by the NKX2-1 lineage factor in lung adenocarcinoma. Pulice JL, Meyerson M. bioRxiv [Preprint]. 2023 Oct 27:2023.10.26.563996. doi: 10.1101/2023.10.26.563996. 10.1101/2023.10.26.563996 PubMed 37994369